Human Wharton's Jelly-Derived Stem Cells Display a Distinct Immunomodulatory and Proregenerative Transcriptional Signature Compared to Bone Marrow-Derived Stem Cells

Stem Cells and Development

Volumn 27, Issue 2, 2018, Pages 65-84

  Donders, Raf ^a   Bogie, Jeroen F J ^a   Ravanidis, Stylianos ^a   Gervois, Pascal ^a   Vanheusden, Marjan ^a   Marée, Raphaël ^b   Schrynemackers, Marie ^b   Smeets, Hubert J M ^c   Pinxteren, Jef ^d   Gijbels, Kristel ^d   Walbers, Sara ^d   Mays, Robert W ^e   Deans, Robert ^e   Van Den Bosch, Ludo ^f   Stinissen, Piet ^a   Lambrichts, Ivo ^a   Gyselaers, Wilfried ^a,g   Hellings, Niels ^a  

^a HASSELT UNIVERSITY   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d ReGenesys BVBA   (Belgium)

^e ATHERSYS INC   (United States)

^f UNIVERSITY OF LEUVEN   (Belgium)

^g DEPARTMENT OF CARDIOLOGY   (Belgium)

Author keywords

immune modulation; MAPC; microarray; MSC; neurotrophic factors; Umbilical cord

Indexed keywords

COLLAGENASE;

ARTICLE; CELL CULTURE; CELL EXPANSION; CELL ISOLATION; CELL MATURATION; CELL REGENERATION; CONTROLLED STUDY; EXPLANT; GENE EXPRESSION PROFILING; GENE ONTOLOGY; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; MESENCHYMAL STEM CELL; PHENOTYPE; PRIORITY JOURNAL; SH-SY5Y CELL LINE; T LYMPHOCYTE; UMBILICAL CORD; WHARTON JELLY; BONE MARROW CELL; CELL ADHESION; CELL PROLIFERATION; COMPARATIVE STUDY; CYTOLOGY; GENE EXPRESSION REGULATION; IMMUNOLOGY; MESENCHYMAL STROMA CELL; PHYSIOLOGY; TUMOR CELL LINE;

BONE MARROW CELLS; CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE ONTOLOGY; HUMANS; IMMUNOMODULATION; MESENCHYMAL STROMAL CELLS;

EID: 85044669757     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2017.0029     Document Type: Article

References (94)

1. Prockop DJ. (1997). Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71-74.
2. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
3. Friedenstein AJ, JF Gorskaja and NN Kulagina. (1976). Fibroblast precursors in normal and irradiated mouse he-matopoietic organs. Exp Hematol 4:267-274.
4. Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, D Prockop and E Horwitz. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317.
5. Ghannam S, C Bouffi, F Djouad, C Jorgensen and D Noel. (2010). Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications. StemCell Res Ther 1:2.
6. Keating A. (2012). Mesenchymal stromal cells: new directions. Cell Stem Cell 10:709-716.
7. Yagi H, A Soto-Gutierrez, B Parekkadan, Y Kitagawa, RG Tompkins, N Kobayashi and ML Yarmush. (2010). Me-senchymal stem cells: mechanisms of immunomodulation and homing. Cell Transplant 19:667-679.
8. Le Blanc K and O Ringden. (2007). Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med 262:509-525.
9. Wexler SA, C Donaldson, P Denning-Kendall, C Rice, B Bradley and JM Hows. (2003). Adult bone marrow is a rich source of human mesenchymal 'stem' cells but umbilical cord and mobilized adult blood are not. Br J Haematol 121: 368-374.
10. Batsali AK, MC Kastrinaki, HA Papadaki and C Pontikoglou. (2013). Mesenchymal stem cells derived from Wharton's Jelly of the umbilical cord: biological properties and emerging clinical applications. Curr Stem Cell Res Ther 8:144-155.
11. Sethe S, A Scutt and A Stolzing. (2006). Aging of mes-enchymal stem cells. Ageing Res Rev 5:91-116.
12. Stenderup K, J Justesen, C Clausen and M Kassem. (2003). Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 33:919-926.
13. Kokai LE, K Marra and JP Rubin. (2014). Adipose stem cells: biology and clinical applications for tissue repair and regeneration. Transl Res 163:399-408.
14. Koninckx R, A Daniels, S Windmolders, U Mees, R Ma-cianskiene, K Mubagwa, P Steels, L Jamaer, J Dubois, et al. (2013). The cardiac atrial appendage stem cell: a new and promising candidate for myocardial repair. Cardiovasc Res 97:413-423.
15. Liu H, S Gronthos and S Shi. (2006). Dental pulp stem cells. Methods Enzymol 419:99-113.
16. Parolini O and M Caruso. (2011). Review: preclinical studies on placenta-derived cells and amniotic membrane: an update. Placenta 32 (Suppl. 2):S186-S195.
17. Lindenmair A, T Hatlapatka, G Kollwig, S Hennerbichler, C Gabriel, S Wolbank, H Redl and C Kasper. (2012). Mesenchymal stem or stromal cells from amnion and um-bilical cord tissue and their potential for clinical applications. Cells 1:1061-1088.
18. McGuckin CP and N Forraz. (2008). Potential for access to embryonic-like cells from human umbilical cord blood. Cell Prolif 41 (Suppl. 1):31-40.
19. Mitchell KE, ML Weiss, BM Mitchell, P Martin, D Davis, L Morales, B Helwig, M Beerenstrauch, K Abou-Easa, et al. (2003). Matrix cells from Wharton's jelly form neu-rons and glia. Stem Cells 21:50-60.
20. Wang HS, SC Hung, ST Peng, CC Huang, HM Wei, YJ Guo, YS Fu, MC Lai and CC Chen. (2004). Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 22:1330-1337.
21. Romanov YA, VA Svintsitskaya and VN Smirnov. (2003). Searching for alternative sources of postnatal human mes-enchymal stem cells: candidate MSC-like cells from um-bilical cord. Stem Cells 21:105-110.
22. Weiss ML, C Anderson, S Medicetty, KB Seshareddy, RJ Weiss, I VanderWerff, D Troyer and KR McIntosh. (2008). Immune properties of human umbilical cord Wharton's jelly-derived cells. Stem Cells 26:2865-2874.
23. Najar M, G Raicevic, HI Boufker, H Fayyad-Kazan, C De Bruyn, N Meuleman, D Bron, M Toungouz and L Lag-neaux. (2010). Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor. Tissue Eng Part A 16:3537-3546.
24. Bongso A and CY Fong. (2013). The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton's jelly of the human umbilical cord. Stem Cell Rev 9:226-240.
25. Dalous J, J Larghero and O Baud. (2012). Transplantation of umbilical cord-derived mesenchymal stem cells as a novel strategy to protect the central nervous system: technical aspects, preclinical studies, and clinical perspectives. Pediatr Res 71:482-490.
26. Troyer DL and ML Weiss. (2008). Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 26: 591-599.
27. Can A and S Karahuseyinoglu. (2007). Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells 25:2886-2895.
28. Weiss ML and DL Troyer. (2006). Stem cells in the umbilical cord. Stem Cell Rev 2:155-162.
29. Pappa KI and NP Anagnou. (2009). Novel sources of fetal stem cells: where do they fit on the developmental continuum? Regen Med 4:423-433.
30. Bianco P, X Cao, PS Frenette, JJ Mao, PG Robey, PJ Simmons and CY Wang. (2013). The meaning, the sense and the significance: translating the science of mesenchy-mal stem cells into medicine. Nat Med 19:35-42.
31. Dore-Duffy P. (2008). Pericytes: pluripotent cells of the blood brain barrier. Curr Pharm Des 14:1581-1593.
32. Blocki A, Y Wang, M Koch, P Peh, S Beyer, P Law, J Hui and M Raghunath. (2013). Not all MSCs can act as peri-cytes: functional in vitro assays to distinguish pericytes from other mesenchymal stem cells in angiogenesis. Stem Cells Dev 22:2347-2355.
33. Struys T, M Moreels, W Martens, R Donders, E Wolfs and I Lambrichts. (2011). Ultrastructural and immunocyto-chemical analysis of multilineage differentiated human dental pulp-and umbilical cord-derived mesenchymal stem cells. Cells Tissues Organs 193:366-378.
34. Hass R, C Kasper, S Bohm and R Jacobs. (2011). Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal 9:12.
35. Schugar RC, SM Chirieleison, KE Wescoe, BT Schmidt, Y Askew, JJ Nance, JM Evron, B Peault and BM Deasy. (2009). High harvest yield, high expansion, and phenotype stability of CD146 mesenchymal stromal cells from whole primitive human umbilical cord tissue. J Biomed Bio-technol 2009:789526.
36. R Core Team (2014). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org/.
37. Gentleman RC, VJ Carey, DM Bates, B Bolstad, M Det-tling, S Dudoit, B Ellis, L Gautier, Y Ge, et al. (2004). Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5:R80.
38. Carvalho BS and RA Irizarry. (2010). A framework for oligonucleotide microarray preprocessing. Bioinformatics 26:2363-2367.
39. Smyth GK. (2005). Limma: linear models for microarray data. In: Bioinformatics and Computational Biology Solutions Using R and Bioconductor. Gentleman R, V Carey, W Huber, R Irizarry and S Dudoit eds. Springer, New York. pp 397-420.
40. Ploner A. (2015). Heatplus: Heatmaps with row and/or column covariates and colored clusters. R package version 2.24.0, https://github.com/alexploner/Heatplus.
41. Gentleman R, V Carey, W Huber and F Hahne. (2014). Genefilter: methods for filtering genes from microarray experiments. R package version 1.46.1.
42. Huang da W, BT Sherman and RA Lempicki. (2009). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57.
43. Huang da W, BT Sherman and RA Lempicki. (2009). Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37:1-13.
44. Bogie JF, S Timmermans, VA Huynh-Thu, A Irrthum, HJ Smeets, JA Gustafsson, KR Steffensen, M Mulder, P Sti-nissen, N Hellings and JJ Hendriks. (2012). Myelin-derived lipids modulate macrophage activity by liver X receptor activation. PLoS One 7:e44998.
45. Edgar R, M Domrachev and AE Lash. (2002). Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30:207-210.
46. Encinas M, M Iglesias, Y Liu, H Wang, A Muhaisen, V Cena, C Gallego and JX Comella. (2000). Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J Neurochem 75:991-1003.
47. Gervois P, E Wolfs, Y Dillen, P Hilkens, J Ratajczak, RB Driesen, T Vangansewinkel, A Bronckaers, B Brone, T Struys and I Lambrichts. (2017). Paracrine maturation and migration of SH-SY5Y cells by dental pulp stem cells. J Dent Res 96:654-662.
48. Gervois P, T Struys, P Hilkens, A Bronckaers, J Ratajczak, C Politis, B Brone, I Lambrichts and W Martens. (2015). Neurogenic maturation of human dental pulp stem cells following neurosphere generation induces morphological and electrophysiological characteristics of functional neurons. Stem Cells Dev 24:296-311.
49. Schindelin J, I Arganda-Carreras, E Frise, V Kaynig, M Longair, T Pietzsch, S Preibisch, C Rueden, S Saalfeld, et al. (2012). Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676-682.
50. Meijering E, M Jacob, JC Sarria, P Steiner, H Hirling and M Unser. (2004). Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images. Cytometry A 58:167-176.
51. Bogie JF, P Stinissen, N Hellings and JJ Hendriks. (2011). Myelin-phagocytosing macrophages modulate autoreactive T cell proliferation. J Neuroinflammation 8:85.
52. Seshareddy K, D Troyer and ML Weiss. (2008). Method to isolate mesenchymal-like cells from Wharton's Jelly of umbilical cord. Methods Cell Biol 86:101-119.
53. Donders R, M Vanheusden, JF Bogie, S Ravanidis, K Thewissen, P Stinissen, W Gyselaers, JJ Hendriks and N Hellings. (2015). Human Wharton's jelly-derived stem cells display immunomodulatory properties and transiently improve rat experimental autoimmune encephalomyelitis. Cell Transplant 24:2077-2098.
54. Caplan AI. (2007). Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213:341-347.
55. Salehinejad P, NB Alitheen, AM Ali, AR Omar, M Mohit, E Janzamin, FS Samani, Z Torshizi and SN Nematollahi-Mahani. (2012). Comparison of different methods for the isolation of mesenchymal stem cells from human umbilical cord Wharton's jelly. In Vitro Cell Dev Biol Anim 48:75-83.
56. Corotchi MC, MA Popa, A Remes, LE Sima, I Gussi and M Lupu Plesu. (2013). Isolation method and xeno-free culture conditions influence multipotent differentiation capacity of human Wharton's jelly-derived mesenchymal stem cells. Stem Cell Res Ther 4:81.
57. Iftimia-Mander A, P Hourd, R Dainty and RJ Thomas. (2013). Mesenchymal stem cell isolation from human umbilical cord tissue: understanding and minimizing variability in cell yield for process optimization. Biopreserv Biobank 11:291-298.
58. Yoon JH, EY Roh, S Shin, NH Jung, EY Song, JY Chang, BJ Kim and HW Jeon. (2013). Comparison of explant-derived and enzymatic digestion-derived MSCs andthe growth factors from Wharton's jelly. Biomed Res Int 2013:428726.
59. Wagner W, P Horn, M Castoldi, A Diehlmann, S Bork, R Saffrich, V Benes, J Blake, S Pfister, V Eckstein and AD Ho. (2008). Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One 3: e2213.
60. Pogozhykh O, D Pogozhykh, AL Neehus, A Hoffmann, R Blasczyk and T Muller. (2015). Molecular and cellular characteristics of human and non-human primate multi-potent stromal cells from the amnion and bone marrow during long term culture. Stem Cell Res Ther 6:150.
61. De Bruyn C, M Najar, G Raicevic, N Meuleman, K Pieters, B Stamatopoulos, A Delforge, D Bron and L Lagneaux. (2011). A rapid, simple, and reproducible method for the isolation of mesenchymal stromal cells from Wharton's jelly without enzymatic treatment. Stem Cells Dev 20:547-557.
62. Kim DW, M Staples, K Shinozuka, P Pantcheva, SD Kang and CV Borlongan. (2013). Wharton's jelly-derived mes-enchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications. Int J Mol Sci 14:11692-11712.
63. Fong CY, LL Chak, A Biswas, JH Tan, K Gauthaman, WK Chan and A Bongso. (2011). Human Wharton's jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells. Stem Cell Rev 7:1-16.
64. Hsieh JY, HW Wang, SJ Chang, KH Liao, IH Lee, WS Lin, CH Wu, WY Lin and SM Cheng. (2013). Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neuro-genesis, and angiogenesis. PLoS One 8:e72604.
65. De Kock J, M Najar, J Bolleyn, F Al Battah, RM Ro-drigues, K Buyl, G Raicevic, O Govaere, S Branson, et al. (2012). Mesoderm-derived stem cells: the link between the transcriptome and their differentiation potential. Stem Cells Dev 21:3309-3323.
66. Jiang Y, BN Jahagirdar, RL Reinhardt, RE Schwartz, CD Keene, XR Ortiz-Gonzalez, M Reyes, T Lenvik, T Lund, et al. (2002). Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49.
67. Ravanidis S, JF Bogie, R Donders, D Craeye, RW Mays, R Deans, K Gijbels, A Bronckaers, P Stinissen, J Pinxteren and N Hellings. (2015). Neuroinflammatory signals enhance the immunomodulatory and neuroprotective properties of multipotent adult progenitor cells. Stem Cell Res Ther 6:176.
68. Subramanian K, M Geraerts, KA Pauwelyn, Y Park, DJ Owens, M Muijtjens, F Ulloa-Montoya, Y Jiang, CM Verfaillie and WS Hu. (2010). Isolation procedure and characterization of multipotent adult progenitor cells from rat bone marrow. Methods Mol Biol 636:55-78.
69. Ulloa-Montoya F, BL Kidder, KA Pauwelyn, LG Chase, A Luttun, A Crabbe, M Geraerts, AA Sharov, Y Piao, et al. (2007). Comparative transcriptome analysis of embryonic and adult stem cells with extended and limited differentiation capacity. Genome Biol 8:R163.
70. Boozer S, N Lehman, U Lakshmipathy, B Love, A Raber, A Maitra, R Deans, MS Rao and AE Ting. (2009). Global characterization and genomic stability of human multistem, a multipotent adult progenitor cell. J Stem Cells 4:17-28.
71. Busch SA, JA Hamilton, KP Horn, FX Cuascut, R Cutrone, N Lehman, RJ Deans, AE Ting, RW Mays and J Silver. (2011). Multipotent adult progenitor cells prevent macrophage-mediated axonal dieback and promote regrowth after spinal cord injury. J Neurosci 31:944-953.
72. Burrows GG, W Van't Hof, LF Newell, A Reddy, PA Wilmarth, LL David, A Raber, A Bogaerts, J Pinxteren, RJ Deans and RT Maziarz. (2013). Dissection of the human multipotent adult progenitor cell secretome by proteomic analysis. Stem Cells Transl Med 2:745-757.
73. La Rocca G, R Anzalone, S Corrao, F Magno, T Loria, M Lo Iacono, A Di Stefano, P Giannuzzi, L Marasa, et al. (2009). Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers. Histochem Cell Biol 131:267-282.
74. Teixeira FG, MM Carvalho, N Sousa and AJ Salgado. (2013). Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration? Cell Mol Life Sci 70:3871-3882.
75. Pluchino S, L Zanotti, E Brambilla, P Rovere-Querini, A Capobianco, C Alfaro-Cervello, G Salani, C Cossetti, G Borsellino, et al. (2009). Immune regulatory neural stem/precursor cells protect from central nervous system auto-immunity by restraining dendritic cell function. PLoS One 4:e5959.
76. Payne NL, G Sun, C McDonald, D Layton, L Moussa, A Emerson-Webber, N Veron, C Siatskas, D Herszfeld, J Price and CC Bernard. (2013). Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination. Cell Transplant 22:1409-1425.
77. Wyatt S, R Andres, H Rohrer and AM Davies. (1999). Regulation of neurotrophin receptor expression by retinoic acid in mouse sympathetic neuroblasts. J Neurosci 19:1062-1071.
78. Pires AO, A Neves-Carvalho, N Sousa and AJ Salgado. (2014). The secretome of bone marrow and wharton jelly derived mesenchymal stem cells induces differentiation and neurite outgrowth in SH-SY5Y Cells. Stem Cells Int 2014: 438352.
79. Park H and MM Poo. (2013). Neurotrophin regulation of neural circuit development and function. Nat Rev Neurosci 14:7-23.
80. Martins LF, RO Costa, JR Pedro, P Aguiar, SC Serra, FG Teixeira, N Sousa, AJ Salgado and RD Almeida. (2017). Mesenchymal stem cells secretome-induced axonal outgrowth is mediated by BDNF. Sci Rep 7:4153.
81. Crigler L, RC Robey, A Asawachaicharn, D Gaupp and DG Phinney. (2006). Human mesenchymal stem cell subpop-ulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol 198:54-64.
82. Ribeiro CA, JS Fraga, M Graos, NM Neves, RL Reis, JM Gimble, N Sousa and AJ Salgado. (2012). The secretome of stem cells isolated from the adipose tissue and Wharton jelly acts differently on central nervous system derived cell populations. Stem Cell Res Ther 3:18.
83. Joerger-Messerli M, M Spinelli, B Oppliger, I Di Salvo, M Mueller, A Schoeberlein and DV Surbek. 394: Neuro-protective and-regenerative effects of exosomes derived from Wharton's jelly mesenchymal stem cells. Am J Obstet Gynecol 216:S236-S237.
84. WeissML, SMedicetty, ARBledsoe, RSRachakatla, MChoi, S Merchav, Y Luo, MS Rao, G Velagaleti and D Troyer. (2006). Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 24:781-792.
85. Koh SH, KS Kim, MR Choi, KH Jung, KS Park, YG Chai, W Roh, SJ Hwang, HJ Ko, et al. (2008). Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats. Brain Res 1229:233-248.
86. Lin YC, TL Ko, YH Shih, MY Lin, TW Fu, HS Hsiao, JY Hsu and YS Fu. (2011). Human umbilical mesenchymal stem cells promote recovery after ischemic stroke. Stroke 42:2045-2053.
87. Yang CC, YH Shih, MH Ko, SY Hsu, H Cheng and YS Fu. (2008). Transplantation of human umbilical mesenchymal stem cells from Wharton's jelly after complete transection of the rat spinal cord. PLoS One 3:e3336.
88. Carvalho MM, FG Teixeira, RL Reis, N Sousa and AJ Salgado. (2011). Mesenchymal stem cells in the umbilical cord: phenotypic characterization, secretome and applications in central nervous system regenerative medicine. Curr Stem Cell Res Ther 6:221-228.
89. Roobrouck VD, K Vanuytsel and CM Verfaillie. (2011). Concise review: culture mediated changes in fate and/or potency of stem cells. Stem Cells 29:583-589.
90. Roobrouck VD, C Clavel, SA Jacobs, F Ulloa-Montoya, S Crippa, A Sohni, SJ Roberts, FP Luyten, SW Van Gool, et al. (2011). Differentiation potential of human postnatal mesen-chymal stem cells, mesoangioblasts, and multipotent adult progenitor cells reflected in their transcriptome and partially influenced by the culture conditions. Stem Cells 29:871-882.
91. Delarosa O, W Dalemans and E Lombardo. (2012). Tolllike receptors as modulators of mesenchymal stem cells. Front Immunol 3:182.
92. Gatta V, M D'Aurora, P Lanuti, L Pierdomenico, S Sper-duti, G Palka, M Gesi, M Marchisio, S Miscia and L Stuppia. (2013). Gene expression modifications in Whar-ton's Jelly mesenchymal stem cells promoted by prolonged in vitro culturing. BMC Genomics 14:635.
93. Klingemann H, D Matzilevich and J Marchand. (2008). Mesenchymal Stem Cells-Sources and Clinical Applications. Transfus Med Hemother 35:272-277.
94. Lee KS, JJ Nah, BC Lee, HT Lee, HS Lee, BJ So and SH Cha. (2013). Maintenance and characterization of multi-potent mesenchymal stem cells isolated from canine umbilical cord matrix by collagenase digestion. Res Vet Sci 94:144-151.